Would you like to know whether it is worthwhile to invest in a biotech company, or whether an existing investment should be held or sold?
Are you wondering whether the risk in your portfolio is spread wide enough?
Do you require a scientifically based assessment of whether an existing portfolio company is on the right track?
In this respect, we look at the entire product range of the companies in your portfolio as well as their competitiveness in the international market. We make forecasts on how the market segment is likely to develop and where companies are positioned in this environment. Investors can thereby identify the relationship between risk and return with precision – and take countermeasures if necessary.
Based on the product and company valuations, it was possible to forecast how the valuation would develop and to determine best moment to sell the company shares.
are you facing? Write to us.
Dr. Raija Kramer